Expedia Inc (EXPE) 113.95 $EXPE Company News for August

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Expedia Inc (EXPE) 113.95 $EXPE

Company News for August 01, 2016
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:10AM CDT
Companies in the News are: XRX,MRK,ABBV,EXPE
MRK: 58.44 (-0.22), EXPE: 113.91 (-3.46), ABBV: 66.14 (-0.80), XRX: 9.93 (-0.21)

Travelport Expands its European Partnership With Expedia
PR Newswire Europe - Mon Aug 01, 2:31AM CDT
BELLEVUE, Washington and LANGLEY, England, August 1, 2016 /PRNewswire/ --
TVPT: 13.12 (-0.41), EXPE: 113.91 (-3.46)

Exxon Mobil and Stericycle stumble; Alphabet and Newell jump
AP - Fri Jul 29, 3:46PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:
CI: 126.39 (-0.40), AMZN: 758.86 (-8.88), EMN: 64.35 (-0.83), NWL: 53.35 (-0.62), EXPE: 113.91 (-3.46), SRCL: 88.05 (-1.32), GOOGL: 796.22 (-4.72), GOOG: 770.97 (-1.91)

Expedia Falls 1.69% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Jul 29, 12:05PM CDT
Expedia (NASDAQ:EXPE) traded in a range yesterday that spanned from a low of $112.99 to a high of $117.93. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $115.80 on volume of 3.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EXPE: 113.91 (-3.46)

Watch for Expedia to Potentially Rebound After Falling 1.69% Yesterday
Comtex SmarTrend(R) - Fri Jul 29, 12:04PM CDT
Expedia (NASDAQ:EXPE) traded in a range yesterday that spanned from a low of $112.99 to a high of $117.93. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $115.80 on volume of 3.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EXPE: 113.91 (-3.46)

Expedia Misses on Top & Bottom Lines, Looking for trivago IPO
Sejuti Banerjea - Zacks Investment Research - Fri Jul 29, 10:45AM CDT
Expedia Inc. (EXPE) shares lost 6.35% in extended trading yesterday, as quarterly revenue results fell short of the Zacks Consensus Estimate.
PETS: 20.68 (-0.13), STMP: 76.30 (-1.83), EXPE: 113.91 (-3.46), EVLV: 1.91 (-0.01)

Watch for Shares of Expedia (EXPE) to Approach Support at $114.88
Comtex SmarTrend(R) - Fri Jul 29, 9:08AM CDT
Shares of Expedia (NASDAQ:EXPE) have bearishly opened below the pivot of $118.42 today and have reached the first support level of $117.08. Should the shares continue to fall, the support pivots of $114.88 and $111.34 will be of interest.
EXPE: 113.91 (-3.46)

The Zacks Analyst Blog Highlights: Amazon, Alphabet, CBS, Wynn Resorts and Expedia
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:30AM CDT
The Zacks Analyst Blog Highlights: Amazon, Alphabet, CBS, Wynn Resorts and Expedia
AMZN: 758.86 (-8.88), EXPE: 113.91 (-3.46), WYNN: 97.09 (-0.84), GOOGL: 796.22 (-4.72), CBS: 51.81 (-0.29)

Expedia Inc. (EXPE) Q2 Earnings, Revenues Fall Short Of Estimates
Adam Clark - Zacks Investment Research - Thu Jul 28, 5:00PM CDT
Expedia Inc. (EXPE) reported its second quarter 2016 financial results after market close on Thursday, posting an earnings and revenue miss, which sent the stock lower in after hour trade.
EXPE: 113.91 (-3.46)

Monster Tech Cos Report Monster Q2 Earnings: Amazon (AMZN), Alphabet (GOOGL) and More
Mark Vickery - Zacks Investment Research - Thu Jul 28, 4:48PM CDT
Amazon (AMZN) and Alphabet (GOOGL) post big earnings beats, and CBS Corp. (CBS) and Wynn Resorts (WYNN) put out positive results as well.
AMZN: 758.86 (-8.88), EXPE: 113.91 (-3.46), WYNN: 97.09 (-0.84), GOOGL: 796.22 (-4.72), CBS: 51.81 (-0.29)

Expedia, Inc. Q2 2016 Earnings Release Available on Company's IR Site
PR Newswire - Thu Jul 28, 3:01PM CDT
Expedia, Inc. (NASDAQ: EXPE) posted its second quarter 2016 earnings release in the Investor Relations section of its corporate website at http://ir.expediainc.com. The earnings release is also available on the Securities and Exchange Commission's website at http://www.sec.gov. As announced previously, the company will host a conference call today to discuss financial results at 1:30 PM Pacific Time / 4:30 PM Eastern Time.
EXPE: 113.91 (-3.46)

5 Stocks to Watch Today Not Named Amazon or Google
ESTMZ - Thu Jul 28, 9:42AM CDT
BIDU : This afternoon we get results from Google and its Chinese counterpart, Baidu. Baidu shareholders haven’t necessarily shared the same experience as those holding Google. The stock is down 13.2% since the start of the year despite consistently...
AMZN: 758.86 (-8.88), DECK: 63.41 (-2.40), WYNN: 97.09 (-0.84), LVS: 49.84 (-0.40), PANW: 125.61 (-2.87), PCLN: 1,331.88 (-24.20), JNPR: 22.34 (-0.26), SPY: 215.39 (-1.55), BIDU: 161.33 (-1.90), EXPE: 113.91 (-3.46), GOOGL: 796.22 (-4.72), FTNT: 33.90 (-0.95), CHKP: 75.20 (-0.89)

Can Anything Stop Amazon from Beating this Quarter?
ESTMZ - Wed Jul 27, 3:30PM CDT
Amazon.com Inc. ( AMZN ) Consumer Discretionary - Internet & Catalog Retail | Reports July 28, After Market Closes. Key Takeaway The Estimize consensus is looking for earnings per share of $1.21 on $29.90 billion in revenue, slightly higher...
NFLX: 93.54 (-0.83), AMZN: 758.86 (-8.88), SPY: 215.39 (-1.55), FB: 122.82 (-1.49), EXPE: 113.91 (-3.46), WMT: 72.90 (-0.88), GOOGL: 796.22 (-4.72), VZ: 54.00 (-0.50), AAPL: 104.61 (-1.44)

Expedia Becomes #47 Most Shorted S&P 500 Component, Replacing C.H. Robinson Worldwide
MarketNewsVideo.com - Wed Jul 27, 1:31PM CDT
The most recent short interest data has been released for the 07/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a...
EXPE: 113.91 (-3.46)

E-commerce Q2 Earnings to Watch on Jul 28: AMZN, EXPE, STMP
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 8:42AM CDT
The Q2 earnings season is in full swing, with as many as 1000 companies, including 189 S&P 500 members, scheduled to post their financial numbers this week.
AMZN: 758.86 (-8.88), STMP: 76.30 (-1.83), EXPE: 113.91 (-3.46)

What's in Store for VeriSign (VRSN) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 5:51PM CDT
VeriSign, Inc. (VRSN) is set to report second-quarter 2016 results on Jul 28.
VRSN: 84.40 (-1.22), INVA: 12.66 (-0.38), EXPE: 113.91 (-3.46), GDDY: 29.40 (-0.94)

Changyou.com (CYOU) Q2 Earnings: Is a Surprise in Store?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 10:19AM CDT
Changyou.com Limited (CYOU) is set to report second-quarter 2016 results on Aug 1.
INVA: 12.66 (-0.38), EXPE: 113.91 (-3.46), CYOU: 20.20 (+0.26), GDDY: 29.40 (-0.94)

Should You Sell Expedia (EXPE) Before Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:33AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and Expedia Inc. (EXPE) may be one such company
EXPE: 113.91 (-3.46)

#TravelHacks for making the most of your travel dollar: Five reasons to book through an online travel agency
PR Newswire - Tue Jul 19, 7:01AM CDT
With the 2016 summer travel season in full swing, Expedia.com® invites consumers to ask themselves a simple question when choosing how to book travel. How can I get the most value? Expedia suggests a simple answer. Book through an online travel agency (OTA) website.
EXPE: 113.91 (-3.46)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 11

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
Infrared Imaging Expands with AI, SWIR: Tech Trends

Updated Category News Views 5

Infrared Imaging: The Backbone of Future Tech Kinda wild how infrared imaging's become a hot topic in tech circles. With the market expected to jump from USD 9.2 billion in 2026 to a hefty USD 12.6 billion by 2031, averaging a 6.4% growth rate, there's plenty to chew on. Even if you ain't the analytical type, it ain't hard to spot where the money's flowing. Infrared's...

Continue Reading
SACHEU Partners with AI to Harness Real Customer Insights

Updated Category News Views 4

Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...

Continue Reading
IWP and SHARE Forge New Path for Filmmaker Funding

Updated Category News Views 4

Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...

Continue Reading
Navigating Hit and Run Protocols in St. Tammany Parish

Updated Category News Views 4

When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...

Continue Reading
SureDone's Taska AI: Transforming Marketplace Listings

Updated Category News Views 5

Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 8

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading
FSC Revives Frank Lloyd Wright's Planetarium Magic

Updated Category News Views 5

The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...

Continue Reading
BlueCollar Backs SuiteWorld 2026 with Platinum Sponsorship

Updated Category News Views 6

BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...

Continue Reading
1.8M Moves in England: The Admin Maze Explained

Updated Category News Views 5

Navigating the Address Change Labyrinth Every time that welcome mat rolls out in a new spot, you're signing up for a mountain of paperwork. Sloth Move just painted a picture of the administrative mess awaiting those 1.8 million English households that decided 'new view, new digs' last year. Their analysis highlights why moving home means more than packing boxes—it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Class Action for Novo Nordisk Investors Today

Updated Category News Views 95

Novo Nordisk A/S Securities Class Action Opportunity Investors who purchased securities of Novo Nordisk A/S (NYSE: NVO) between specific dates have a significant opportunity to engage in a class action lawsuit. This lawsuit is rooted in claims pertaining to misrepresentation of crucial details surrounding the company's clinical trial outcomes and announcements made by the...

Continue Reading
Understanding the Potential Fed Rate Cut: NFP Insights

Updated Category News Views 116

The Implications of the NFP Report on Fed Decisions This month’s jobs report is critical, particularly due to anticipated benchmark revisions to past employment figures. These revisions may indicate more than a million jobs could be adjusted, leading to discussions about a potential rate cut by the Federal Reserve. Key Expectations for the NFP Report Analysts forecast...

Continue Reading
Explore Vegamour's Innovation in Hair Growth Supplements Today

Updated Category News Views 352

Vegamour Unveils GRO+ Advanced Hair Growth Supplements Vegamour, a leader in plant-powered biotech dedicated to enhancing hair longevity, has recently announced a groundbreaking product: the GRO+ Advanced Hair Growth & Density Supplements. This new dual-pill system is designed to combat hair thinning through a unique internal approach that prioritizes health and wellness....

Continue Reading
Coalfire Launches ISO 42001 Certification for Responsible AI Management

Updated Category News Views 384

Coalfire Pioneers ISO 42001 Certification for AI Governance Coalfire is leading the cybersecurity industry by becoming one of the first organizations accredited by the ANSI National Accreditation Board (ANAB) for the ISO/IEC 42001:2023 standard, dedicated to Artificial Intelligence governance. The Need for AI Governance As AI technologies continue to advance rapidly, the...

Continue Reading
Akeso's Ivonescimab Sets New Standards in NSCLC Treatment

Updated Category News Views 143

Akeso's Groundbreaking Clinical Trial Results Akeso, Inc. (9926.HK) is thrilled to share significant breakthroughs from its Phase III clinical study of ivonescimab, a cutting-edge PD-1/VEGF bispecific antibody designed to treat non-small cell lung cancer (NSCLC). The study, known as HARMONi-2/AK112-303, has garnered attention following its publication in The Lancet, one...

Continue Reading